Top of page
Health

African Caribbean type 1 diabetics at greater risk of losing sight

Woman doing eye test with optometrist in eye sight clinic

African Caribbean people with type 1 diabetes are at 39% greater risk of developing sight-threatening diabetic retinopathy, which if untreated can lead to blindness.

The paper, published today in Diabetes Care and led by researchers from King’s, adds much needed evidence to show the relationship between ethnicity and type 1 diabetes-related retinopathy.

Diabetic retinopathy is caused by high blood sugar levels damaging the retina, which is located at the back of the eye. It can take years for diabetic retinopathy to threaten eyesight if not diagnosed and treated. Diabetic retinopathy is the leading cause of blindness in working age people in the UK and many other countries.

The study followed a diverse population group from South London over six years who had type 1 diabetes but no signs of retinopathy. By the end of study, they found African Caribbean ethnicity is a risk factor for sight-threatening diabetic retinopathy, even when adjusted for traditional risk predictors such glucose control and blood pressure as well as socioeconomic status. The study also found the African Caribbean and the Caucasian group, which had the least risk, attended the same number of eye screenings.

Researchers warn that more thorough eye exams are needed for at-risk groups.

We undertook this study because there is no previous studies in people with type 1 diabetes of the potential impact of ethnicity on diabetic retinopathy. Our novel observation that people with type 1 diabetes of African Caribbean ethnicity are at 39% greater risk of sight threating retinopathy independent of conventional risk factors suggests that enhanced retinal surveillance and risk factor control may be needed in such higher risk groups.– Dr Janaka Karalliedde, Clinical Reader in Diabetes and Cardiovascular Diseasenone

Hilary Nathan policy director at JDRF, the type 1 diabetes charity said ‘Sight loss is devastating. This is important research because it helps us begin to understand how rates of type 1 diabetes disease progression can be more aggressive across different ethnicity patient populations. Findings like these can help evidence and design more personalised treatment pathways helping to prevent sight loss and disability.”

Miss Evelyn Mensah, Clinical Lead for Ophthalmology at London North West University Healthcare NHS Trust, who was not involved in the study, said: “Since the Covid-19 pandemic, there has been sharp focus on the ethnic health inequalities that currently exist. Previous studies have traditionally aggregated non-white ethnic groups into Black, Asian and minority ethnic. Identifying that the risk of sight threatening diabetic retinopathy is 39% greater in African Caribbean people is a shocking finding. Evidence suggests racial differences in central retinal thickness (CRT) measurements where the CRT is thinner in Black people compared to their white counterparts. This means more fluid would be required in a thinner macula compared to a thicker macula to be eligible for NICE approved intravitreal anti-VEGF treatments.

“In addition, data from the Diabetic Retinopathy Clinical Research (DRCR) Retina Network clinical trials suggests underrepresentation in the enrolment of Black participants compared with the expected disease burden and racial distribution of diabetic retinopathy. The work by King’s College London researchers is a significant contribution to the body of evidence that health inequalities exist for Black people with Type 1 diabetes. Further analysis is required to determine the reasons why this disparity exists.”

The study was funded by Guy’s & St Thomas’ Charity and involved academics and clinicians from King’s Health Partners.

 

You might also like

kid boy Upset, sitting in the dark kid boy Upset, sitting in the dark

Childhood maltreatment accounts to 40% of mental health conditions

The mental health conditions examined were anxiety, depression, harmful alcohol…

Doctor holding a digital tablet with x-ray of brain and skull skeleton Doctor holding a digital tablet with x-ray of brain and skull skeleton

WHO and France host high-level meeting to tackle meningitis

Global leaders highlight the need to defeat meningitis – a leading…

a teenage with autism relaxing with rocking chair a teenage with autism relaxing with rocking chair

Specialist autism diagnostic service launches for at-risk young people

A first-of-its-kind service is underway from this month to provide…

Shelby Rowe, second from right, executive director of the Suicide Prevention Resource Center at the University of Oklahoma, speaks at a White House panel discussion Tuesday with actress Ashley Judd, second from left, and singer-songwriter Aloe Blacc, right. The discussion, facilitated by U.S. Surgeon General Vivek Murthy, M.D., MBA, left, was held to mark the release of the National Strategy for Suicide Prevention. Shelby Rowe, second from right, executive director of the Suicide Prevention Resource Center at the University of Oklahoma, speaks at a White House panel discussion Tuesday with actress Ashley Judd, second from left, and singer-songwriter Aloe Blacc, right. The discussion, facilitated by U.S. Surgeon General Vivek Murthy, M.D., MBA, left, was held to mark the release of the National Strategy for Suicide Prevention.

University of Oklahoma assists in New National Suicide Prevention Plan

The Biden-Harris Administration, through the U.S. Department of Health and…